Detect-ION and Moffitt Cancer Center Collaborate to Revolutionize Lung Cancer Early Detection
The pilot project partnership envisions breath diagnostics to be an in-home screening that is fast, inexpensive, and as easy as...
Cancer
Safe Seated Mammography Using Enable Me’s VELA Mammography Chair Can Improve Image Clarity this World Breast Cancer Research Day Aug. 18
The clinically designed, technician friendly and FDA-approved VELA Mammography Chair is transforming women's typically uncomfortable and often painful standing mammography...
Genmab Announces Changes to its Executive Committee
Media Release COPENHAGEN, Denmark; August 16, 2024 Rayne Waller joins as Executive Vice President and Chief Technology OfficerBrad Bailey appointed...
AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update
– Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications – Company...
Science in Space to Cure Disease on Earth–the International Space Station National Lab and NASA Announce New Funding Opportunity
Joint solicitation will award up to $4 million for biomedical R&D leveraging the orbiting laboratory KENNEDY SPACE CENTER, Fla., Aug....
Mellie Appoints Two Industry Leaders to Its Advisory Board
SAN FRANCISCO, Aug. 15, 2024 /PRNewswire/ -- Mellie, an award-winning eldercare and special needs family caregiver support solution, announced the...
The American Journal of Gastroenterology Publishes Esopredict Performance Results from Pivotal Clinical Validation Study
Results demonstrate Esopredict's ability to predict the likelihood of progression to high-grade dysplasia or esophageal adenocarcinoma in patients with Barrett's...
Fractal Launches vaidya.ai, a Multimodal Health Assistant
NEW YORK, Aug. 15, 2024 /PRNewswire/ -- Fractal (www.fractal.ai), a global provider of artificial intelligence (AI) and advanced analytics solutions to...
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
Potentially pivotal GBM study evaluating lead program, Berubicin, enrollment completed; Topline data expected in the first half of 2025Recent strategic...
CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update
Closed new licensing agreement with GSK worth up to €1.45 billion, including €400 million upfront; provides strong validation of CureVac's...
CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma
First patient administered in dose-confirmation Part B of Phase 1 study with mRNA-based, multiepitope cancer vaccine candidate CVGBMPart B expected...
CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / August 15, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company...
International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific Assembly
NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF), in partnership with the National Medical Association...
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Marlborough, Massachusetts--(Newsfile Corp. - August 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary...
Chromatography Market size is set to grow by USD 3.99 billion from 2024-2028, Increasing number of conferences and symposiums to boost the market growth, Technavio
NEW YORK, Aug. 14, 2024 /PRNewswire/ -- The global chromatography market size is estimated to grow by USD 3.99 billion...
Embr Labs, Recognized as Leading Menopause innovator by Femtech World, Launches on Amazon in the UK
BOSTON, Aug. 14, 2024 /PRNewswire/ -- Embr Labs, Inc, makers of Embr Wave®, the leading temperature wearable, today announced the...
Ludwig Announces Substantial Corporate Initiatives
Revealia™, the world’s most convenient cancer screening test, to launch in 2024 SPARKS, NV / ACCESSWIRE / August 14, 2024...
American Shared Hospital Services Announces Second Quarter 2024 Earnings Conference Call
Call Scheduled for Today at 6:30 PM ETSAN FRANCISCO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE...
RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Phase III clinical trial is evaluating RenovoGem™ for the treatment of Locally Advanced Pancreatic Cancer UNMC opened enrollment of TIGeR-PaC...
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
WILMETTE, Ill., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing...